LEP and type 2 diabetes mellitus: There is renewed use of antidiabetic agents such as thiazolidinediones [40] and metformin [41] that have modest effects on abdominal obesity, as well as leptin analogs to determine whether use of these agents may ameliorate cognitive decline in individuals with T2D [42].